Latest Macular edema Stories
TARRYTOWN, N.Y., Feb. 26, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
RnRMarketResearch.com adds “Diabetic Macular Edema – Pipeline Review, H1 2015” report to its store.
In patients with moderate or worse vision loss at baseline, those treated with EYLEA gained, on average, an additional full line or more on an eye chart when compared to those treated with alternative
TARRYTOWN, N.Y., Jan. 23, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
ATLANTA, Jan. 14, 2015 /PRNewswire/ -- Alimera Sciences, Inc.
ATLANTA, Dec. 1, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
TARRYTOWN, N.Y., Dec. 1, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S.
TARRYTOWN, N.Y., Nov. 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd.
ATLANTA, Nov. 17, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.